Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Index funds vary in tax efficiency; choosing the right ones can lower taxable gains and boost after-tax returns. This guide covers tax-smart picks and strategies.
23,826 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Mortgage rates rose again this week as inflation fears and geopolitical tensions weighed on bonds. The latest Freddie...
Pi Network says it has solved crypto’s biggest problem by tying token use to verified user engagement and sustained u...
Quantum stocks have been front and center as grants and hype push prices higher. This guide explains why infleqtion s...
Rivian is pursuing a Tesla-inspired playbook: start with a premium model, scale up production, then roll out a mass-m...
A draft framework for ending the war between Iran and the U.S. appears close to finalization, with Hormuz talks inclu...
A director sale can grab attention, but IPG Photonics is quietly reshaping its core business. Here’s how the brand is...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
Charles Hoskinson pivots back to Cardano as Midnight winds toward a close after a $250 million investment in Wyoming....
REMAX Select reports a sharp rise in transaction sides driven by collaboration across markets, earning a top-10 place...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
Investors are rethinking where to place bets as AI hype cools. Transportation stocks offer diversification and exposu...